BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6285549)

  • 1. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of intravenous glucagon test in insulinoma.
    Oneda A; Maruhama Y; Itabashi H; Horigome K; Yanbe A
    Tohoku J Exp Med; 1975 Jul; 116(3):205-11. PubMed ID: 170711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
    McMahon MM; O'Brien PC; Service FJ
    Mayo Clin Proc; 1989 Dec; 64(12):1481-8. PubMed ID: 2557494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nightly amended IRI/BG ratio in fasting test during sleeping periods in subjects with insulinoma and in normal, diabetic and obese subjects.
    Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
    Acta Diabetol Lat; 1984; 21(4):325-32. PubMed ID: 6099025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.
    Rastogi GK; Sialy R; Sinha MK; Dash R; Chopra JS; Kataria RN
    Acta Diabetol Lat; 1975; 12(5-6):309-23. PubMed ID: 181932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.
    Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1984; 45(3):155-60. PubMed ID: 6098216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin studies in the diagnosis of insulinoma.
    McKiddie MT; Buchanan KD; Abernethy RJ
    Scott Med J; 1969 Jun; 14(6):200-8. PubMed ID: 4307323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and treatment of insulinomas--analysis of 6 cases].
    Yang JZ
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):389-91. PubMed ID: 2559838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
    Gorini M; Ghizzi A; Carlo Stella C; De Caro L
    Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon test for insulinoma: a chemical study in 25 cases.
    Marks V; Samols E
    J Clin Pathol; 1968 May; 21(3):346-52. PubMed ID: 4301688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism of insulin and immunoreactive insulin-like substances (proinsulin, HWIRI) in vivo in man].
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1982; 43(1):15-21. PubMed ID: 6291446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    J Endocrinol Invest; 1982; 5(5):315-21. PubMed ID: 6296220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinoma with normal plasma insulin concentrations and insulin/glucose ratios during hypoglycemic episodes.
    Hattori N; Ishihara T; Saiki Y; Moridera K; Hino M; Ikekubo K; Kurahachi H
    Intern Med; 1994 Dec; 33(12):813-6. PubMed ID: 7718969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood sugar, serum insulin and free fatty acid interrelationships during intravenous tolbutamide testing in normal young adults and in patients with insulinoma.
    Grunt JA; Pallotta JA; Soeldner JS
    Diabetes; 1970 Feb; 19(2):122-6. PubMed ID: 4313182
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties.
    Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U
    J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia: tolbutamide and leucine tests in insulinoma.
    Frawley TF; Pensuwan S
    Med Clin North Am; 1968 Mar; 52(2):283-94. PubMed ID: 4297807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.